Cost-effectiveness of digital interventions for mental health: current evidence, common misconceptions, and future directions
Open Access
- 21 October 2024
- journal article
- editorial
- Published by Frontiers Media SA in Frontiers in Digital Health
- Vol. 6, 1486728
Abstract
Digital interventions have been relevant for mental health problems for a decade now. Digital interventions have been instrumental in addressing mental health problems for over a decade. These technology-based tools are designed to provide psychological support and facilitate therapeutic activities for individuals experiencing mental health challenges. They include Internet-based programs and mobile applications, among many other digital tools, that apparently promised an accessible, scaled, and economically efficient solution. In 2019, approximately 1 in 8 individuals, equating to 970 million people globally, were affected by a mental disorder, with anxiety and depressive disorders being the most prevalent (1). As mental health disorders continue to exert significant pressure on global health systems and economies, assessing the cost-effectiveness of these digital interventions becomes increasingly critical.Economic evaluations address the fundamental economic problem of scarcity, where the demand for resources is greater than what is available (2). In healthcare, this will be balancing the choices between alternatives so as to maximize health outcomes in the face of a certain budget. This requires a rigorous analysis of the costs and benefits of different healthcare services, ensuring that resources are allocated efficiently and effectively. Economic evaluations in healthcare have evolved significantly since the 1960s (3). The development of quality-adjusted life years (QALYs) in the early 1970s represented a huge step forward in that it provided a single measure allowing comparisons of the relative effectiveness of different healthcare interventions (4,5). The development of disabilityadjusted life years (DALYs) by the World Bank and WHO in 1990 further refined this approach by incorporating both morbidity and mortality into the assessment (6). It was also during the 1990s that the major institutions in this regard, shaping the field of pharmacoeconomics, were set up -the International Society for Pharmacoeconomics and Outcomes Research and journals like "Pharmacoeconomics" and "Value in Health. These advancements are indicative of an increasing realization of the important role played by economic evaluations in healthcare decision-making processes.Economic evaluations compare the costs and outcomes of different healthcare services to determine which provide the best value for money. The primary techniques employed encompass (2):-Cost-Benefit Analysis (CBA): This framework monetizes the cost and benefits of different interventions, making it easier for policymakers to understand the financial return on investment. For every euro or dollar invested, the return is expressed in euro or dollar, for instance. CBA is often considered more intuitive for decision-makers because it directly relates to financial outcomes. -Cost-Effectiveness Analysis (CEA): CEA evaluates interventions based on their costs relative to their health outcomes, typically measured in natural units such as life years gained or symptoms reduced. This method is particularly useful for comparing interventions that have similar goals but different costs and effectiveness profiles. -Cost-Utility Analysis (CUA): CUA uses a generic index of morbidity and mortality, such as QALYs or DALYs, to compare the value of different interventions. This approach allows for a standardized comparison across diverse health conditions. The Incremental Cost-Effectiveness Ratio (ICER) is a key metric in these analyses, representing the additional cost per additional unit of health benefit (e.g., cost per QALY gained) when comparing two interventions (2). This metric is crucial in determining whether an intervention is considered costeffective within a given context. In addition, the cost-effectiveness plane is often used to visualize these comparisons, plotting cost and effect pairs of different interventions relative to each other (7).Research on the cost-effectiveness of digital interventions, particularly for mental health disorders like depression and anxiety, has produced promising results. Numerous systematic reviews have demonstrated that guided internet interventions for depression and anxiety appear to be costeffective compared to controls (8)(9)(10)(11)(12)(13). However, Kolovos et al. (14) found in an individual participant data meta-analysis that internet interventions for the treatment of depression were not considered cost-effective. The evidence for digital interventions in treating substance use disorders is similarly mixed but generally positive. Buntrock et al. (15) reviewed 11 studies and found that the likelihood of internet interventions being cost-effective in this area appears promising. This suggests that digital interventions have the potential to address a wide range of mental health issues, extending beyond depression and anxiety. Despite this potential, interventions aimed at the same condition often differ in their underlying principles, content, and the type and extent of support offered. It is important to consider that these variations may influence treatment outcomes and raise questions about whether evidence from similar interventions can be effectively combined to create comprehensive recommendations regarding their cost-effectiveness.There are several misconceptions when interpreting results of economic evaluations. A prevalent misconception is that "cost-effective interventions" are synonymous with "being cheap" or "saving money". Cost-effectiveness measures the value of an intervention by comparing the health outcomes achieved per unit of cost, rather than just the total cost. It assesses the relative costs and benefits of different interventions to determine which offers the best health outcomes for the money spent. An intervention is deemed cost-effective if it provides a good balance between the costs incurred and the health benefits gained, typically measured in quality-adjusted life years...Keywords
This publication has 21 references indexed in Scilit:
- Systematic review of economic evaluations for internet- and mobile-based interventions for mental health problemsnpj Digital Medicine, 2022
- Control interventions in randomised trials among people with mental health disordersCochrane Database of Systematic Reviews, 2022
- Economic Evaluations of Internet-Based Psychological Interventions for Anxiety Disorders and Depression: A Systematic ReviewJournal of Affective Disorders, 2021
- A systematic review of trial-based economic evaluations of internet- and mobile-based interventions for substance use disordersEuropean Journal of Public Health, 2019
- Cost effectiveness of guided Internet-based interventions for depression in comparison with control conditions: An individual-participant data meta-analysisDepression and Anxiety, 2018
- Economic evaluations of internet- and mobile-based interventions for the treatment and prevention of depression: A systematic reviewJournal of Affective Disorders, 2018
- Cost-effectiveness of interventions for treating anxiety disorders: A systematic reviewJournal of Affective Disorders, 2017
- Designing a Cost-Effectiveness Analysis2016
- Economic evaluations of Internet interventions for mental health: a systematic reviewPsychological Medicine, 2015
- Timely and Complete Publication of Economic Evaluations Alongside Randomized Controlled TrialsPharmacoEconomics, 2012